Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Taxes × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 7 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Lung Neoplasms 5 Fallopian Tube Neoplasms 5 Endometrial Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Breast Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Rectal Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Locally Advanced Cervical Adenocarcinoma 1 Gastric Adenocarcinoma 1

Interventions

Specimen Handling 7 Biopsy 6 ruxolitinib 2 fludarabine 2 decitabine and cedazuridine drug combination 2 Azacitidine 2 venetoclax 1 veliparib 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fedratinib 1 axatilimab 1 Topotecan 1 Tacrolimus 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Methotrexate 1 Melphalan 1 Janus Kinase Inhibitors 1 Injections 1 Idarubicin 1 High-Energy Shock Waves 1 Granulocyte Colony-Stimulating Factor 1 Geritol 1 Edetic Acid 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡